Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Koch

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Scientific Reports|November 23, 2023
Efficacy of combined tumor irradiation and K<sub>Ca</sub>3.1-targeting with TRAM-34 in a syngeneic glioma mouse modelNicolai Stransky, Katrin Ganser, Leticia Quintanilla-Martinez, et al.
Future Medicinal Chemistry|June 5, 2014
Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discoveryMarkus O Zimmermann, Andreas Lange, Rainer Wilcken, et al.
European Journal of Medicinal Chemistry|May 17, 2019
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitorsFabian Heider, Francesco Ansideri, Roberta Tesch, et al.
Journal of Medicinal Chemistry|May 22, 2025
A "Ligand First" Approach toward Selective, Covalent JNK2/3 InhibitorsValentin R Wydra, Nicole Plank, Stefan Zwirner, et al.
Journal of Medicinal Chemistry|September 3, 2025
High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS<sub>1</sub>R LigandsFabian J Ertl, Anna Friedel, Elena J Schmid, et al.
European Journal of Medicinal Chemistry|July 27, 2024
Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stabilitySimon Scheuerer, Lucia Motlova, Linda Schäker-Hübner, et al.
Diabetes Technology & Therapeutics|July 2, 2025
Cost-Utility Analysis of the MiniMed<b>™</b> 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People with Type 1 Diabetes in FranceHelene Hanaire, Asli Zeynep Ozdemir Saltik, Richard F Pollock, et al.
International Journal of Cancer|June 28, 2024
K<sub>Ca</sub> channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K<sub>Ca</sub> expression levelsKatrin Ganser, Nicolai Stransky, Tayeb Abed, et al.
Chemmedchem|May 13, 2014
8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseasesAndreas Brunschweiger, Pierre Koch, Miriam Schlenk, et al.
Journal of Medicinal Chemistry|March 9, 2022
Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y<sub>1</sub> ReceptorChristoph Müller, Jakob Gleixner, Maris-Johanna Tahk, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Scientific Reports|November 23, 2023
Efficacy of combined tumor irradiation and K<sub>Ca</sub>3.1-targeting with TRAM-34 in a syngeneic glioma mouse modelNicolai Stransky, Katrin Ganser, Leticia Quintanilla-Martinez, et al.
Future Medicinal Chemistry|June 5, 2014
Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discoveryMarkus O Zimmermann, Andreas Lange, Rainer Wilcken, et al.
European Journal of Medicinal Chemistry|May 17, 2019
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitorsFabian Heider, Francesco Ansideri, Roberta Tesch, et al.
Journal of Medicinal Chemistry|May 22, 2025
A "Ligand First" Approach toward Selective, Covalent JNK2/3 InhibitorsValentin R Wydra, Nicole Plank, Stefan Zwirner, et al.
Journal of Medicinal Chemistry|September 3, 2025
High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS<sub>1</sub>R LigandsFabian J Ertl, Anna Friedel, Elena J Schmid, et al.
European Journal of Medicinal Chemistry|July 27, 2024
Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stabilitySimon Scheuerer, Lucia Motlova, Linda Schäker-Hübner, et al.
Diabetes Technology & Therapeutics|July 2, 2025
Cost-Utility Analysis of the MiniMed<b>™</b> 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People with Type 1 Diabetes in FranceHelene Hanaire, Asli Zeynep Ozdemir Saltik, Richard F Pollock, et al.
International Journal of Cancer|June 28, 2024
K<sub>Ca</sub> channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K<sub>Ca</sub> expression levelsKatrin Ganser, Nicolai Stransky, Tayeb Abed, et al.
Chemmedchem|May 13, 2014
8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseasesAndreas Brunschweiger, Pierre Koch, Miriam Schlenk, et al.
Journal of Medicinal Chemistry|March 9, 2022
Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y<sub>1</sub> ReceptorChristoph Müller, Jakob Gleixner, Maris-Johanna Tahk, et al.
Pageof 8